Nicholas Jason Singer Amends Eterna Therapeutics Stake

TL;DR

**Nicholas Jason Singer updated his Eterna Therapeutics ownership, signaling a change in his stake.**

AI Summary

Nicholas Jason Singer, a U.S. citizen, filed an Amendment No. 3 to Schedule 13G for Eterna Therapeutics Inc. (ticker not provided, CUSIP 114082209) on January 19, 2024, indicating his beneficial ownership of the company's common stock as of December 31, 2023. This filing, under Rule 13d-1(c), updates his previous disclosures regarding his stake in the pharmaceutical preparations company. This matters to investors as it provides transparency into significant shareholder activity, potentially signaling confidence or a change in strategy from a notable individual investor.

Why It Matters

This filing updates the public on Nicholas Jason Singer's beneficial ownership in Eterna Therapeutics Inc., offering transparency into a significant investor's position. Investors can use this information to track major shareholder movements and potentially infer sentiment or future actions.

Risk Assessment

Risk Level: low — This is a routine amendment filing, not indicating any immediate financial distress or major corporate event.

Analyst Insight

Investors should note Nicholas Jason Singer's continued involvement and monitor future filings for changes in his beneficial ownership, as this could signal his evolving view on Eterna Therapeutics Inc.'s prospects.

Key Numbers

• 114082209 — CUSIP Number (Identifies Eterna Therapeutics Inc.'s common stock for trading and regulatory purposes.)
• 005-42217 — SEC File Number (Unique identifier for Eterna Therapeutics Inc.'s filings with the SEC.)
• 3 — Amendment Number (Indicates this is the third amendment to Nicholas Jason Singer's Schedule 13G filing for Eterna Therapeutics Inc.)

Key Players & Entities

• Nicholas Jason Singer (person) — reporting person and beneficial owner
• Eterna Therapeutics Inc. (company) — subject company, issuer of common stock
• 03 Life Sciences (company) — organization name associated with Eterna Therapeutics Inc.
• Purchase Capital LLC (company) — group member mentioned in the filing
• December 31, 2023 (date) — date of event requiring the filing
• January 19, 2024 (date) — filing date
• $0.005 (dollar_amount) — par value per share of Eterna Therapeutics Inc. common stock

Forward-Looking Statements

• Nicholas Jason Singer will continue to be a significant beneficial owner of Eterna Therapeutics Inc. common stock. (Nicholas Jason Singer) — medium confidence, target: December 31, 2024

FAQ

Key Financial Figures

• $0.005 — me of Issuer) Common stock, par value $0.005 per share (Title of Class of Securiti
• $3.28 — Common Stock, with an exercise price of $3.28 per share (as subsequently amended by t
• $1.43 — s subsequently amended by the Issuer to $1.43 per share). In addition, Pacific Premie
• $1,000,000 — ly 2023 Private Placement ”): (i) $1,000,000 in principal amount of the Issuer&rsquo
• $2.61 — e Common Stock, at an exercise price of $2.61 per share, as subsequently amended by t
• $2.86 — of Common Stock at conversion prices of $2.86 and $1.9194 per share, respectively, in
• $1.9194 — Stock at conversion prices of $2.86 and $1.9194 per share, respectively, in each case s

Filing Documents

• ea191815-13ga3singer_eterna.htm (SC 13G/A) — 58KB
• 0001213900-24-004707.txt ( ) — 60KB

If this statement is filed pursuant to §§240.13d-1(b)

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable. 4

Ownership

Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. The information contained in Item 5 through and including Item 11 on each Reporting Person’s cover page of this Schedule 13G, including the footnotes thereto, is incorporated by reference in this Item 4.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following .

Ownership of More than Five Percent on Behalf of another

Item 6. Ownership of More than Five Percent on Behalf of another Person Not applicable.

Identification and Classification of the Subsidiary

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable.

Identification and Classification of Members of the

Item 8. Identification and Classification of Members of the Group Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not Applicable.

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 19, 2024 /s/ Nicholas J. Singer Name: Nicholas J. Singer PURCHASE CAPITAL LLC By: /s/ Nicholas J. Singer Name: Nicholas J. Singer Title: Managing Partner 6

View Full Filing

View this SC 13G/A filing on SEC EDGAR